Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00119262 | Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer | completed | Phase 2 | 226 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT01367028 | A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer(ABCSG 32) | completed | Phase 2 | 100 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | May 13, 2014 |
| clinicaltrials |
| NCT00057941 | Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer | completed | Phase 2 | 148 | National Cancer Institute (NCI)NIH | 1 | May 12, 2014 | clinicaltrials |
| NCT01335152 | Online Stress Management and Coping Skills Training for Women With Breast Cancer | completed | Phase 1 / Phase 2 | 100 | Talaria, IncINDUSTRY | 1 | May 7, 2014 | clinicaltrials |
| NCT00039520 | Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer | completed | Phase 2 | 10 | Fox Chase Cancer CenterOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT00369655 | VEGF Trap in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | May 5, 2014 | clinicaltrials |
| NCT01129622 | Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)(RFCLET2) | completed | Phase 2 | 16 | Mount Sinai Hospital, CanadaOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT00559507 | Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2014 | clinicaltrials |
| NCT02119715 | A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy | completed | Phase 2 | 182 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 22, 2014 | clinicaltrials |
| NCT01127763 | RAD001 Plus Carboplatin in Breast Cancer Patients | completed | Phase 2 | 25 | NYU Langone HealthOTHER | 1 | Apr 9, 2014 | clinicaltrials |
| NCT00645333 | Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 4, 2014 | clinicaltrials |
| NCT01215162 | Phase II Study of Intra-Operative Electron Irradiation and External Beam Irradiation After Lumpectomy in Patients With T1N0M0 and T2N0M0 Breast Cancer | completed | Phase 2 | 65 | Mayo ClinicOTHER | 1 | Apr 3, 2014 | clinicaltrials |
| NCT00600249 | Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer. | completed | Phase 2 | 35 | Centre Jean PerrinOTHER | 1 | Mar 20, 2014 | clinicaltrials |
| NCT01594177 | Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy(DAFNE) | completed | Phase 2 | 65 | GBG Forschungs GmbHOTHER | 1 | Mar 13, 2014 | clinicaltrials |
| NCT00193063 | Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer | completed | Phase 2 | 41 | SCRI Development Innovations, LLCOTHER | 0 | Mar 12, 2014 | clinicaltrials |
| NCT00450866 | Epothilone B in Treating Patients With CNS Metastases From Breast Cancer | completed | Phase 2 | 55 | David Peereboom, MDOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT00615940 | Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer | completed | Phase 2 | 132 | Heidelberg Pharma AGINDUSTRY | 5 | Feb 28, 2014 | clinicaltrials |
| NCT02067481 | Effect of a Diet and Physical Activity Intervention in Breast Cancer Survivors(PREDICOP-F) | completed | Phase 2 | 42 | Institut Català d'OncologiaOTHER | 1 | Feb 20, 2014 | clinicaltrials |
| NCT00091832 | Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer | completed | Phase 2 | 255 | AmgenINDUSTRY | 0 | Jan 28, 2014 | clinicaltrials |
| NCT01045304 | Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer | completed | Phase 2 | 163 | SanofiINDUSTRY | 6 | Jan 14, 2014 | clinicaltrials |
| NCT00006381 | Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00070031 | Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00101400 | BAY43-9006 - Phase II in Advanced Breast Cancer | completed | Phase 2 | 54 | BayerINDUSTRY | 2 | Dec 13, 2013 | clinicaltrials |
| NCT00212069 | Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer | completed | Phase 2 | 30 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00005873 | Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00811369 | Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer(ZAMBONEY) | completed | Phase 2 | 126 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Nov 18, 2013 | clinicaltrials |
| NCT00004237 | Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00022204 | Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00066378 | Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer | completed | Phase 2 | 71 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Oct 24, 2013 | clinicaltrials |
| NCT00043017 | Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer(ACRIN 6657) | completed | Phase 2 | 356 | American College of Radiology Imaging NetworkNETWORK | 1 | Oct 9, 2013 | clinicaltrials |
| NCT00006228 | Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | completed | Phase 2 | 76 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 7, 2013 | clinicaltrials |
| NCT00392392 | Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer | completed | Phase 2 | 29 | SCRI Development Innovations, LLCOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01038804 | A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer | completed | Phase 2 | 101 | Astellas Pharma IncINDUSTRY | 8 | Sep 18, 2013 | clinicaltrials |
| NCT00104702 | Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer(GERICO03) | completed | Phase 2 | 46 | UNICANCEROTHER | 1 | Sep 4, 2013 | clinicaltrials |
| NCT00424203 | Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | completed | Phase 2 | 40 | UNICANCEROTHER | 1 | Sep 4, 2013 | clinicaltrials |
| NCT01554943 | Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients | completed | Phase 2 | 73 | Jules Bordet InstituteOTHER | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00266331 | RayGel-An Alternative for Skin Care During External Beam Radiation | completed | Phase 2 | 150 | Nathalie JohnsonOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00321633 | Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer | completed | Phase 2 | 148 | University College London HospitalsOTHER | 6 | Aug 26, 2013 | clinicaltrials |
| NCT00005635 | Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 | completed | Phase 2 | — | Genentech, Inc.INDUSTRY | 1 | Aug 20, 2013 | clinicaltrials |
| NCT00965523 | Study of E7389 for Advanced or Metastatic Breast Cancer | completed | Phase 2 | 81 | Eisai Co., Ltd.INDUSTRY | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00284180 | Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer | completed | Phase 2 | 32 | SCRI Development Innovations, LLCOTHER | 1 | Aug 9, 2013 | clinicaltrials |
| NCT00978770 | MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer | completed | Phase 2 | 50 | Cancer Clinical Trials Unit, ScotlandOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00193037 | Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer | completed | Phase 2 | 102 | SCRI Development Innovations, LLCOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT01380808 | Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC) | completed | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT00574301 | Percutaneous Removal and Margin Ablation for Breast Cancer | completed | Phase 1 / Phase 2 | 32 | University of ArkansasOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT00002680 | Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer | completed | Phase 2 | 40 | Yale UniversityOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT01387841 | Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting | completed | Phase 2 | 120 | Bharath Charitable Cancer Hospital and InstituteOTHER | 1 | Jul 24, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 15, 2014source: clinicaltrials